{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:02:49Z","timestamp":1790352169956,"version":"4.1.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Polycystic Ovary Syndrome (PCOS) is a highly prevalent and heterogenous endocrinopathy affecting 5-18% of women. Although its cardinal features include androgen excess, ovulatory dysfunction, and\/or polycystic ovarian morphology, women often display related metabolic manifestations, including hyperinsulinaemia, insulin resistance, and obesity. Emerging data reveal that the hormonal alterations associated with PCOS also impact bone metabolism. However, inconsistent evidence exists as to whether PCOS is a bone-protective or bone-hindering disorder with an accumulating body of clinical data indicating that hyperandrogenism, hyperinsulinaemia, insulin resistance, and obesity may have a relative protective influence on bone, whereas chronic low-grade inflammation and vitamin D deficiency may adversely affect bone health. Herein, we provide a comprehensive assessment of the endocrine and metabolic manifestations associated with PCOS and their relative effects on bone metabolism. We focus principally on clinical studies in women investigating their contribution to the alterations in bone turnover markers, bone mineral density, and ultimately fracture risk in PCOS. A thorough understanding in this regard will indicate whether women with PCOS require enhanced surveillance of bone health in routine clinical practice.<\/jats:p>","DOI":"10.3389\/fendo.2023.1163771","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T06:32:25Z","timestamp":1683873145000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of distinct Polycystic Ovary Syndrome phenotypes on bone health"],"prefix":"10.3389","volume":"14","author":[{"given":"Edouard G.","family":"Mills","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Abbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waljit S.","family":"Dhillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Comninos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/NRENDO.2018.24","article-title":"Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment","volume":"14","author":"Escobar-Morreale","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/J.ENDMTS.2021.100085","article-title":"A review: brief insight into polycystic ovarian syndrome","volume":"3","author":"Bulsara","year":"2021","journal-title":"Endocr Metab Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/CEN.14704","article-title":"Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS)","volume":"97","author":"Garg","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Fauser","year":"2004","journal-title":"Fertil Steril"},{"key":"B6","volume-title":"Steering committee of the national institute of health evidence-based methodology workshop on polycystic ovary syndrome. final report","author":"DePaolo","year":"2012"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2020.00516","article-title":"Fundamental concepts and novel aspects of polycystic ovarian syndrome: expert consensus resolutions","volume":"11","author":"Aversa","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1210\/ENDREV\/BNAB015","article-title":"The relationship between bone and reproductive hormones beyond estrogens and androgens","volume":"42","author":"Mills","year":"2021","journal-title":"Endocr Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1210\/CLINEM\/DGAC117","article-title":"Acute effects of kisspeptin administration on bone metabolism in healthy men","volume":"107","author":"Comninos","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2022.923791","article-title":"Bone perspectives in functional hypothalamic amenorrhoea: an update and future avenues","volume":"13","author":"Behary","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/S007740170029","article-title":"Relationship between bone mineral density and insulin resistance in polycystic ovary syndrome","volume":"19","author":"Y\u00fcksel","year":"2001","journal-title":"J Bone Miner Metab"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/J.JPAG.2011.12.073","article-title":"A comparison of bone mineral density in normal weight and obese adolescents with polycystic ovary syndrome","volume":"25","author":"To","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/S40618-014-0175-5","article-title":"Bone mineral density in women with polycystic ovary syndrome","volume":"37","author":"Katulski","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1250256","article-title":"Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients","volume":"33","author":"Karada\u011f","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/HUMUPD\/DMZ020","article-title":"Negative impact of polycystic ovary syndrome on bone health: a systematic review and meta-analysis","volume":"25","author":"Piovezan","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/S00774-021-01302-6","article-title":"Bone markers and bone mineral density associates with periodontitis in females with poly-cystic ovarian syndrome","volume":"40","author":"Zia","year":"2022","journal-title":"J Bone Miner Metab"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(99)00203-4","article-title":"Bone mineral density and body composition in lean women with polycystic ovary syndrome","volume":"72","author":"Good","year":"1999","journal-title":"Fertil Steril"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1046\/J.1365-2265.1998.3691182.X","article-title":"Effect of hyperandrogenism and menstrual cycle abnormalities on bone mass and bone turnover in young women","volume":"48","author":"Adami","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2004.01.031","article-title":"The association of bone mineral density with insulin resistance in patients with polycystic ovary syndrome","volume":"115","author":"Noyan","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0398","article-title":"Correlates of increased lean muscle mass in women with polycystic ovary syndrome","volume":"161","author":"Carmina","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2265.2012.04378.X","article-title":"Body composition, bone mineral density and fractures in late postmenopausal women with polycystic ovary syndrome - a long-term follow-up study","volume":"77","author":"Schmidt","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B22","first-page":"261","article-title":"Polycystic ovary syndrome in university students: occurrence and associated factors","volume":"8","author":"Attlee","year":"2014","journal-title":"Int J Fertil Steril"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/DMRR.2767","article-title":"The relationships of irisin with bone mineral density and body composition in PCOS patients","volume":"32","author":"Gao","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1055\/A-0733-7768","article-title":"Bone mineral density is unaltered in women with polycystic ovary syndrome","volume":"50","author":"Ganie","year":"2018","journal-title":"Horm Metab Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1159\/000507079","article-title":"Obesity and insulin resistance, not polycystic ovary syndrome, are independent predictors of bone mineral density in adolescents and young women","volume":"92","author":"Pereira-Eshraghi","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/JBMR.2737","article-title":"Fracture risk is decreased in women with polycystic ovary syndrome: a register-based and population-based cohort study","volume":"31","author":"Rubin","year":"2016","journal-title":"J Bone Miner Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/S00774-017-0894-8","article-title":"Increased risk of fractures in patients with polycystic ovary syndrome: a nationwide population-based retrospective cohort study","volume":"36","author":"Yang","year":"2018","journal-title":"J Bone Miner Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/J.FERTNSTERT.2006.11.149","article-title":"Diagnostic criteria for polycystic ovary syndrome in Taiwanese Chinese women: comparison between Rotterdam 2003 and NIH 1990","volume":"88","author":"Hsu","year":"2007","journal-title":"Fertil Steril"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/J.STEROIDS.2013.04.006","article-title":"Ethnic differences in the phenotypic expression of polycystic ovary syndrome","volume":"78","author":"Zhao","year":"2013","journal-title":"Steroids"},{"key":"B30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5653\/CERM.2015.42.3.86","article-title":"Clinical characteristics in Taiwanese women with polycystic ovary syndrome","volume":"42","author":"Hsu","year":"2015","journal-title":"Clin Exp Reprod Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1089\/ANDRO.2021.0020\/ASSET\/IMAGES\/LARGE\/ANDRO.2021.0020_FIGURE1.JPEG","article-title":"Hyperandrogenism in women with polycystic ovarian syndrome: pathophysiology and controversies","volume":"3","author":"Kanbour","year":"2022","journal-title":"Androgens"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/J.FERTNSTERT.2008.12.138","article-title":"Prevalence of hyperandrogenemia in the polycystic ovary syndrome diagnosed by the national institutes of health 1990 criteria","volume":"93","author":"Huang","year":"2010","journal-title":"Fertil Steril"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1515\/HMBCI-2016-0047","article-title":"Hyperandrogenemia in women with polycystic ovary syndrome: prevalence, characteristics and association with body mass index","volume":"29","author":"Alexiou","year":"2017","journal-title":"Horm Mol Biol Clin Investig"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1152\/PHYSREV.00033.2015","article-title":"Estrogens and androgens in skeletal physiology and pathophysiology","volume":"97","author":"Almeida","year":"2017","journal-title":"Physiol Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.3.854","article-title":"Identification of androgen receptors in normal human osteoblast-like cells","volume":"86","author":"Colvard","year":"1989","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/endo-124-3-1576","article-title":"Androgens directly stimulate proliferation of bone cells in vitro","volume":"124","author":"Kasperk","year":"1989","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1007\/BF00295958","article-title":"Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells","volume":"54","author":"Mizuno","year":"1994","journal-title":"Calcif Tissue Int"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220093","article-title":"Sex steroid metabolism in the tibial growth plate of the rat","volume":"143","author":"Van Der Eerden","year":"2002","journal-title":"Endocrinology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.10.4319","article-title":"The localization of androgen receptors in human bone","volume":"82","author":"Abu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1159\/000023310","article-title":"Androgen receptors in bone-forming tissue","volume":"51","author":"Noble","year":"1999","journal-title":"Horm Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.9.5359","article-title":"The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage","volume":"138","author":"Weinstein","year":"1997","journal-title":"Endocrinology"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/J.FERTNSTERT.2005.06.017","article-title":"Effects of testosterone on cancellous bone, marrow adipocytes, and ovarian phenotype in a young female rat model of polycystic ovary syndrome","volume":"84","author":"Tamura","year":"2005","journal-title":"Fertil Steril"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1055\/A-1284-5491","article-title":"Trabecular bone is increased in a rat model of polycystic ovary syndrome","volume":"129","author":"Mujica","year":"2021","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0084","article-title":"Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment","volume":"89","author":"Sinha-Hikim","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2165\/11536910-000000000-00000","article-title":"Testosterone physiology in resistance exercise and training: the up-stream regulatory elements","volume":"40","author":"Vingren","year":"2010","journal-title":"Sports Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.83.6.4892","article-title":"Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity","volume":"83","author":"Mauras","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1053\/jcrc.2000.0150012","article-title":"The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury","volume":"15","author":"Demling","year":"2000","journal-title":"J Crit Care"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/JBMR.5650040320","article-title":"Muscle strength, physical fitness, and weight but not age predict femoral neck bone mass","volume":"4","author":"Pocock","year":"1989","journal-title":"J Bone Miner Res"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1093\/GERONA\/GLX188","article-title":"Longitudinal changes in muscle mass and strength, and bone mass in older adults: gender-specific associations between muscle and bone losses","volume":"73","author":"Kim","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01450-8","article-title":"Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome","volume":"98","author":"Douchi","year":"2001","journal-title":"Obstet Gynecol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/J.MEHY.2006.03.057","article-title":"Polycystic ovary syndrome in men: stein-leventhal syndrome revisited","volume":"68","author":"Kurzrock","year":"2007","journal-title":"Med Hypotheses"},{"key":"B52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/JCEM.84.1.5382","article-title":"Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families","volume":"84","author":"Govind","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/HUMREP\/DEI070","article-title":"Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum Reprod"},{"key":"B54","doi-asserted-by":"publisher","first-page":"116285","DOI":"10.1016\/J.BONE.2021.116285","article-title":"Genetic risk for the polycystic ovary syndrome, bone mineral density and fractures in women and men: a UK biobank mendelian randomisation study","volume":"155","author":"Deshmukh","year":"2022","journal-title":"Bone"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PGEN.1007813","article-title":"Large-Scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PloS Genet"},{"key":"B56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/s0015-0282(02)02968-0","article-title":"Androgen effects on bone and muscle","volume":"77","author":"Notelovitz","year":"2002","journal-title":"Fertil Steril"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2015-3543","article-title":"Weight gain and dyslipidemia in early adulthood associate with polycystic ovary syndrome: prospective cohort study","volume":"101","author":"Ollila","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/1179558119874042","article-title":"Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies","volume":"13","author":"Barber","year":"2019","journal-title":"Clin Med Insights Reprod Health"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1111\/CEN.14421","article-title":"Obesity and polycystic ovary syndrome","volume":"95","author":"Barber","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/S42000-018-0018-4","article-title":"Obesity and bone metabolism","volume":"17","author":"Savvidis","year":"2018","journal-title":"Hormones (Athens)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/FCELL.2020.600181","article-title":"Obesity and bone health: a complex link","volume":"8","author":"Hou","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1177\/2042018815611004","article-title":"The obesity of bone","volume":"6","author":"Greco","year":"2015","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.03.210","article-title":"Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast","volume":"331","author":"Oshima","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.8.8346","article-title":"Leptin reduces ovariectomy-induced bone loss in rats","volume":"142","author":"Burguera","year":"2001","journal-title":"Endocrinology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.2.200","article-title":"Leptin inhibits osteoclast generation","volume":"17","author":"Holloway","year":"2002","journal-title":"J Bone Miner Res"},{"key":"B66","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0092-8674(00)81558-5","article-title":"Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass","volume":"100","author":"Ducy","year":"2000","journal-title":"Cell"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308744101","article-title":"Serum leptin level is a regulator of bone mass","volume":"101","author":"Elefteriou","year":"2004","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/1749-799X-6-30","article-title":"Effects of obesity on bone metabolism","volume":"6","author":"Cao","year":"2011","journal-title":"J Orthop Surg Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/IJOS.2015.1","article-title":"Fibroblast growth factor 23 and bone mineralisation","volume":"7","author":"Guo","year":"2015","journal-title":"Int J Oral Sci"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2019.1689550","article-title":"Fibroblast growth factor 23 and 25(OH)D levels are related to abdominal obesity and cardiovascular risk in patients with polycystic ovarian syndrome","volume":"36","author":"Gateva","year":"2020","journal-title":"Gynecol Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (AE-PCOS) society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/IJMS23052500","article-title":"Fibroblast growth factor 23 and osteoporosis: evidence from bench to bedside","volume":"23","author":"Sirikul","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment","volume":"14","author":"Xing","year":"2022","journal-title":"Int J Womens Health"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/J.1447-0756.2009.01133.X","article-title":"Difference in non-weight-bearing effects on bone mineral density between trunk and peripheral fat mass in women with polycystic ovary syndrome","volume":"36","author":"Yanazume","year":"2010","journal-title":"J Obstet Gynaecol Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/J.FERTNSTERT.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM-62-5-904","article-title":"Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism","volume":"62","author":"Barbierit","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/JCEM.83.6.4886","article-title":"Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system","volume":"83","author":"Nestler","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/ar.1092140205","article-title":"In vivo demonstration by radioautography of binding sites for insulin in liver, kidney, and calcified tissues of the rat","volume":"214","author":"Martineau-Doiz\u00e9","year":"1986","journal-title":"Anat Rec"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.06.002","article-title":"Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition","volume":"142","author":"Fulzele","year":"2010","journal-title":"Cell"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/s8756-3282(98)00095-7","article-title":"Insulin receptor expression in primary and cultured osteoclast-like cells","volume":"23","author":"Thomas","year":"1998","journal-title":"Bone"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.diff.2012.02.002","article-title":"Insulin receptor isoforms are differently expressed during human osteoblastogenesis","volume":"83","author":"Avnet","year":"2012","journal-title":"Differentiation"},{"key":"B82","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/cbf.2801","article-title":"Effects of insulin and insulin-like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via akt and ERK","volume":"30","author":"Zhang","year":"2012","journal-title":"Cell Biochem Funct"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1038\/NRENDO.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00223-014-9931-Y","article-title":"Osteocalcin: an osteoblast-derived polypeptide hormone that modulates whole body energy metabolism","volume":"96","author":"Brennan-Speranza","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2018.00794","article-title":"Osteocalcin-a versatile bone-derived hormone","volume":"9","author":"Moser","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1007\/S00774-010-0211-2","article-title":"Serum concentrations of carboxylated osteocalcin are increased and associated with several components of the polycystic ovarian syndrome","volume":"29","author":"Diamanti-Kandarakis","year":"2011","journal-title":"J Bone Miner Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.2174\/1381612811319320012","article-title":"Mediators of low-grade chronic inflammation in polycystic ovary syndrome (PCOS)","volume":"19","author":"Ojeda-Ojeda","year":"2013","journal-title":"Curr Pharm Des"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/J.FERTNSTERT.2010.11.036","article-title":"Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis","volume":"95","author":"Escobar-Morreale","year":"2011","journal-title":"Fertil Steril"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/J.SEMARTHRIT.2015.04.014","article-title":"Evolutionary medicine and bone loss in chronic inflammatory diseases\u2013a theory of inflammation-related osteopenia","volume":"45","author":"Straub","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"B90","doi-asserted-by":"publisher","first-page":"120847","DOI":"10.1016\/J.LFS.2022.120847","article-title":"Targeting chronic inflammation as a potential adjuvant therapy for osteoporosis","volume":"306","author":"Livshits","year":"2022","journal-title":"Life Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/306378a0","article-title":"An interleukin 1 like factor stimulates bone resorption","volume":"306","author":"Gowen","year":"1983","journal-title":"vitro Nat"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1172\/JCI5703","article-title":"IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis","volume":"103","author":"Kotake","year":"1999","journal-title":"J Clin Invest"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1084\/jem.191.2.275","article-title":"Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction","volume":"191","author":"Kobayashi","year":"2000","journal-title":"J Exp Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2003.10.005","article-title":"IL-6, RANKL, TNF-alpha\/IL-1: interrelations in bone resorption pathophysiology","volume":"15","author":"Kwan Tat","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/ijms23031786","article-title":"Interplay between inflammation and pathological bone resorption: insights into recent mechanisms and pathways in related diseases for future perspectives","volume":"23","author":"Terkawi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02182","article-title":"Chemokines in physiological and pathological bone remodeling","volume":"10","author":"Brylka","year":"2019","journal-title":"Front Immunol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/s1043-4666(03)00106-6","article-title":"Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor","volume":"22","author":"Abbas","year":"2003","journal-title":"Cytokine"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1002\/art.24920","article-title":"Tumor necrosis factor alpha and interleukin-1beta modulate calcium and nitric oxide signaling in mechanically stimulated osteocytes","volume":"60","author":"Bakker","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.511799","article-title":"The effect of inflammation on bone","volume":"11","author":"Epsley","year":"2020","journal-title":"Front Physiol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1136\/GUT.2004.044370","article-title":"The RANKL\/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss","volume":"54","author":"Moschen","year":"2005","journal-title":"Gut"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1073\/PNAS.1400544111\/-\/DCSUPPLEMENTAL\/PNAS.201400544SI.PDF","article-title":"OPG\/RANKL\/RANK axis is a critical inflammatory signaling system in ischemic brain in mice","volume":"111","author":"Shimamura","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0107","article-title":"Serum osteoprotegerin concentrations are decreased in women with the polycystic ovary syndrome","volume":"159","author":"Escobar-Morreale","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1136\/JCP.2010.086595","article-title":"Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis","volume":"64","author":"Jabbar","year":"2011","journal-title":"J Clin Pathol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2020.00951","article-title":"Growth\/Differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint","volume":"11","author":"Wischhusen","year":"2020","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/J.DIFF.2009.07.008","article-title":"Growth\/differentiation factor-15 inhibits differentiation into osteoclasts\u2013a novel factor involved in control of osteoclast differentiation","volume":"78","author":"Va\u0148hara","year":"2009","journal-title":"Differentiation"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1002\/JBMR.1538","article-title":"Positive regulation of osteoclastic differentiation by growth differentiation factor 15 upregulated in osteocytic cells under hypoxia","volume":"27","author":"Hinoi","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/S00774-013-0560-8","article-title":"Association of plasma GDF-9 or GDF-15 levels with bone parameters in polycystic ovary syndrome","volume":"33","author":"Berberoglu","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"B108","doi-asserted-by":"publisher","first-page":"3432","DOI":"10.1038\/S41598-017-03685-X","article-title":"Competing factors link to bone health in polycystic ovary syndrome: chronic low-grade inflammation takes a toll","volume":"7","author":"Kalyan","year":"2017","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/J.AMJCARD.2010.02.017","article-title":"Relation of c-reactive protein to abdominal adiposity","volume":"106","author":"Brooks","year":"2010","journal-title":"Am J Cardiol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1592\/PHCO.30.5.442","article-title":"Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy","volume":"30","author":"Kalyan","year":"2010","journal-title":"Pharmacotherapy"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.38","article-title":"Periodontal diseases","volume":"3","author":"Kinane","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3390\/JCM9051586","article-title":"Association between periodontal diseases and polycystic ovary syndrome: a systematic review","volume":"9","author":"M\u00e1rquez-Arrico","year":"2020","journal-title":"J Clin Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2022.2070595","article-title":"Vitamin d: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin d and its metabolites","volume":"59","author":"Janou\u0161ek","year":"2022","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1093\/NUTRIT\/NUAC068","article-title":"Effect of supplemental vitamin D3 on bone mineral density: a systematic review and meta-analysis","volume":"81","author":"Kazemian","year":"2022","journal-title":"Nutr Rev"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365-2265.2012.04434.X","article-title":"Vitamin d in the aetiology and management of polycystic ovary syndrome","volume":"77","author":"Thomson","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B116","unstructured":"Vitamin d deficiency in adults | health topics a to z | CKS | NICE"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1007\/S10815-010-9506-4","article-title":"Influence of gene variants related to calcium homeostasis on biochemical parameters of women with polycystic ovary syndrome","volume":"28","author":"Ranjzad","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/J.GENE.2012.11.049","article-title":"Genetic polymorphism of vitamin d receptor gene affects the phenotype of PCOS","volume":"515","author":"Zadeh-Vakili","year":"2013","journal-title":"Gene"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-11-0134","article-title":"Vitamin d-associated polymorphisms are related to insulin resistance and vitamin d deficiency in polycystic ovary syndrome","volume":"164","author":"Wehr","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/J.METABOL.2011.03.002","article-title":"Vitamin d deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome","volume":"60","author":"Li","year":"2011","journal-title":"Metabolism"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/J.CLNU.2020.09.024","article-title":"Androgens and hirsutism score of overweight women with polycystic ovary syndrome improved after vitamin d treatment: a randomized placebo controlled clinical trial","volume":"40","author":"Al-Bayyari","year":"2021","journal-title":"Clin Nutr"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3390\/NU7064555","article-title":"Serum vitamin d levels and polycystic ovary syndrome: a systematic review and meta-analysis","volume":"7","author":"He","year":"2015","journal-title":"Nutrients"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2020.00171","article-title":"Vitamin d deficiency is associated with metabolic risk factors in women with polycystic ovary syndrome: a cross-sectional study in shaanxi China","volume":"11","author":"Wang","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2020.1813272","article-title":"Effects of vitamin d supplementation on metabolic parameters of women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials","volume":"37","author":"Wang","year":"2021","journal-title":"Gynecol Endocrinol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/HUMREP\/DEAA371","article-title":"Measuring the global disease burden of polycystic ovary syndrome in 194 countries: global burden of disease study 2017","volume":"36","author":"Liu","year":"2021","journal-title":"Hum Reprod"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.3389\/FENDO.2020.00099","article-title":"Evolutionary perspectives on the developing skeleton and implications for lifelong health","volume":"11","author":"Kralick","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B127","doi-asserted-by":"publisher","first-page":"115163","DOI":"10.1016\/J.BONE.2019.115163","article-title":"Age at attainment of peak bone mineral density and its associated factors: the national health and nutrition examination survey 2005-2014","volume":"131","author":"Xue","year":"2020","journal-title":"Bone"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1111\/CEN.13456","article-title":"Bone markers in polycystic ovary syndrome: a multicentre study","volume":"87","author":"Lingaiah","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/S00198-016-3617-4","article-title":"The effects of weight loss approaches on bone mineral density in adults: a systematic review and meta-analysis of randomized controlled trials","volume":"27","author":"Soltani","year":"2016","journal-title":"Osteoporos Int"},{"key":"B130","doi-asserted-by":"publisher","first-page":"100248","DOI":"10.1016\/J.BONR.2020.100248","article-title":"Effect of a pulse-based diet and aerobic exercise on bone measures and body composition in women with polycystic ovary syndrome: a randomized controlled trial","volume":"12","author":"McBreairty","year":"2020","journal-title":"Bone Rep"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/S00125-009-1395-7","article-title":"Effect of non-oil-seed pulses on glycaemic control: a systematic review and meta-analysis of randomised controlled experimental trials in people with and without diabetes","volume":"52","author":"Sievenpiper","year":"2009","journal-title":"Diabetologia"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1111\/CEN.14098","article-title":"Prevalence of polycystic ovary syndrome in women with severe obesity - effects of a structured weight loss programme","volume":"91","author":"Kataoka","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1111\/JOIM.12651","article-title":"Effect of monthly high-dose vitamin d on bone density in community-dwelling older adults substudy of a randomized controlled trial","volume":"282","author":"Reid","year":"2017","journal-title":"J Intern Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1002\/JBMR.3442","article-title":"25-hydroxyvitamin d threshold for the effects of vitamin d supplements on bone density: secondary analysis of a randomized controlled trial","volume":"33","author":"Macdonald","year":"2018","journal-title":"J Bone Miner Res"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1093\/HUMUPD\/DMV025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1038\/S41586-022-04431-8","article-title":"Low-dose metformin targets the lysosomal AMPK pathway through PEN2","volume":"603","author":"Ma","year":"2022","journal-title":"Nature"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/J.FERTNSTERT.2019.04.013","article-title":"Metformin decreases bone turnover markers in polycystic ovary syndrome: a post hoc study","volume":"112","author":"Lingaiah","year":"2019","journal-title":"Fertil Steril"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/J.FERTNSTERT.2010.12.002","article-title":"The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study","volume":"95","author":"Ladson","year":"2011","journal-title":"Fertil Steril"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-16-0373","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: morbidity in polycystic ovary syndrome","volume":"176","author":"Glintborg","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1007\/S12020-015-0625-7","article-title":"Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome","volume":"50","author":"Moran","year":"2015","journal-title":"Endocrine"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01495-8","article-title":"A prospective, controlled study of the effects of hormonal contraception on bone mineral density","volume":"98","author":"Berenson","year":"2001","journal-title":"Obstet Gynecol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"CD006033","DOI":"10.1002\/14651858.CD006033.PUB5","article-title":"Steroidal contraceptives: effect on bone fractures in women","volume":"2014","author":"Lopez","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"B143","doi-asserted-by":"publisher","first-page":"791","DOI":"10.3109\/09513590.2010.491572","article-title":"Thiazolinedione treatment in PCOS\u2013an update","volume":"26","author":"Glintborg","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1210\/EN.2003-0746","article-title":"Bone is a target for the antidiabetic compound rosiglitazone","volume":"145","author":"Rzonca","year":"2004","journal-title":"Endocrinology"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1210\/EN.2004-0735","article-title":"Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation","volume":"146","author":"Ali","year":"2005","journal-title":"Endocrinology"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3275\/8767","article-title":"Plasma osteoprotegerin is associated with testosterone levels but unaffected by pioglitazone treatment in patients with polycystic ovary syndrome","volume":"36","author":"Glintborg","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1210\/JC.2007-2249","article-title":"Association of pioglitazone treatment with decreased bone mineral density in obese premenopausal patients with polycystic ovary syndrome: a randomized, placebo-controlled trial","volume":"93","author":"Glintborg","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1163771\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T06:32:33Z","timestamp":1683873153000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1163771\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":147,"alternative-id":["10.3389\/fendo.2023.1163771"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1163771","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"article-number":"1163771"}}